Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

28.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
28.0K
Gene Therapy00:59

Gene Therapy

4.8K
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive molecules for regenerative pulp capping.

European cells & materials·2021
Same author

Evaluation of BMP2/miRNA co-expression systems for potent therapeutic efficacy in bone-tissue regeneration.

European cells & materials·2021
Same author

Repopulation of decellularised articular cartilage by laser-based matrix engraving.

EBioMedicine·2021
Same author

Stromal vascular fraction cells as biologic coating of mesh for hernia repair.

Hernia : the journal of hernias and abdominal wall surgery·2020
Same author

Histomorphometric Analysis of Callus Formation Stimulated by Axial Dynamisation in a Standardised Ovine Osteotomy Model.

BioMed research international·2019
Same author

Adipose-tissue-derived therapeutic cells in their natural environment as an autologous cell therapy strategy: the microtissue-stromal vascular fraction.

European cells & materials·2019

Related Experiment Video

Updated: Mar 24, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

788

Improved osteogenic vector for non-viral gene therapy.

A R Hacobian1, K Posa-Markaryan, S Sperger

  • 1Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, Donaueschingenstrasse 13, A-1200 Vienna, Austria.ara.hacobian@trauma.lbg.ac.at.

European Cells & Materials
|March 21, 2016
PubMed
Summary

Optimizing the bone morphogenetic protein-2 (BMP-2) gene expression system enhances non-viral gene delivery efficiency. This improvement compensates for low transfection rates, making it more suitable for bone regeneration therapies.

More Related Videos

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

10.2K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids
07:14

Enhanced Gene Delivery and Expression using Intraosseous Injection of Chitosan Nanoparticles Encapsulated Adenine Base Editor Plasmids

Published on: May 16, 2025

788
Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers
12:30

Vascular Gene Transfer from Metallic Stent Surfaces Using Adenoviral Vectors Tethered through Hydrolysable Cross-linkers

Published on: August 12, 2014

10.2K
Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
09:54

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

8.6K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Gene Therapy

Background:

  • Bone regeneration therapies face challenges due to deficient bone formation.
  • Non-viral gene delivery of bone morphogenetic protein-2 (BMP-2) offers a promising approach for sustained growth factor expression.
  • Low transfection efficiency of non-viral methods limits therapeutic applications.

Purpose of the Study:

  • To improve a BMP-2 gene expression system to overcome low transfection efficiency.
  • To enhance BMP-2 expression for therapeutic compensation of deficient bone regeneration.

Main Methods:

  • Modified the native BMP-2 gene sequence through codon optimization and insertion of a truncated artificial intron.
  • Transfected multiple cell lines and rat adipose-derived mesenchymal stem cells (rASCs) with the improved BMP-2 construct.
  • Compared the efficacy of the elongation factor 1 alpha (EF1α) promoter against the CMV promoter for BMP-2 expression.
  • Screened various protein secretion signals using reporter proteins.

Main Results:

  • The optimized BMP-2 sequence significantly increased expression rates and osteogenic differentiation in transfected cells.
  • The EF1α promoter demonstrated higher BMP-2 expression compared to the CMV promoter in rASCs.
  • The EF1α promoter showed reduced sensitivity to silencing effects in rASCs.
  • No superior protein secretion signals were identified to replace the native BMP-2 signal.

Conclusions:

  • Enhancing the exogenous BMP-2 expression system can compensate for low transfection efficiencies in gene therapy.
  • Improved non-viral gene delivery systems are more suitable for tissue regeneration applications.
  • This optimized system holds potential for advancing therapeutic strategies for bone regeneration.